Tau protein kinases: involvement in Alzheimer's disease

L Martin, X Latypova, CM Wilson, A Magnaudeix… - Ageing research …, 2013 - Elsevier
Tau phosphorylation is regulated by a balance between tau kinase and phosphatase
activities. Disruption of this equilibrium was suggested to be at the origin of abnormal tau …

Roscovitine in cancer and other diseases

J Cicenas, K Kalyan, A Sorokinas… - Annals of …, 2015 - pmc.ncbi.nlm.nih.gov
Roscovitine [CY-202,(R)-Roscovitine, Seliciclib] is a small molecule that inhibits cyclin-
dependent kinases (CDKs) through direct competition at the ATP-binding site. It is a broad …

The CDK inhibitor CR8 acts as a molecular glue degrader that depletes cyclin K

M Słabicki, Z Kozicka, G Petzold, YD Li, M Manojkumar… - Nature, 2020 - nature.com
Molecular glue compounds induce protein–protein interactions that, in the context of a
ubiquitin ligase, lead to protein degradation. Unlike traditional enzyme inhibitors, these …

[HTML][HTML] A review on mechanistic insight of plant derived anticancer bioactive phytocompounds and their structure activity relationship

K Mazumder, A Aktar, P Roy, B Biswas, ME Hossain… - Molecules, 2022 - mdpi.com
Cancer is a disorder that rigorously affects the human population worldwide. There is a
steady demand for new remedies to both treat and prevent this life-threatening sickness due …

The role of tau in Alzheimer's disease and related disorders

R Medeiros, D Baglietto‐Vargas… - CNS neuroscience & …, 2011 - Wiley Online Library
Tau, the microtubule‐associated protein, forms insoluble filaments that accumulate as
neurofibrillary tangles in Alzheimer's disease (AD) and related tauopathies. Under …

Meta-Selective CAr–H Nitration of Arenes through a Ru3(CO)12-Catalyzed Ortho-Metalation Strategy

Z Fan, J Ni, A Zhang - Journal of the American Chemical Society, 2016 - ACS Publications
The first example of transition metal-catalyzed meta-selective CAr–H nitration of arenes is
described. With the use of Ru3 (CO) 12 as the catalyst and Cu (NO3) 2· 3H2O as the nitro …

Recent advances in the multitarget‐directed ligands approach for the treatment of Alzheimer's disease

R Leon, AG Garcia… - Medicinal research …, 2013 - Wiley Online Library
With 27 million cases worldwide documented in 2006, Alzheimer's disease (AD) constitutes
an overwhelming health, social, economic, and political problem to nations. Unless a new …

Circadian timing in cancer treatments

F Lévi, A Okyar, S Dulong, PF Innominato… - Annual review of …, 2010 - annualreviews.org
The circadian timing system is composed of molecular clocks, which drive 24-h changes in
xenobiotic metabolism and detoxification, cell cycle events, DNA repair, apoptosis, and …

The CK1 family: contribution to cellular stress response and its role in carcinogenesis

U Knippschild, M Krüger, J Richter, P Xu… - Frontiers in …, 2014 - frontiersin.org
Members of the highly conserved and ubiquitously expressed pleiotropic CK1 family play
major regulatory roles in many cellular processes including DNA-processing and repair …

Amyloid cascade hypothesis for the treatment of alzheimer's disease: progress and challenges

T Wu, D Lin, Y Cheng, S Jiang, MW Riaz… - Aging and …, 2022 - pmc.ncbi.nlm.nih.gov
The amyloid cascade hypothesis has always been a research focus in the therapeutic field
of Alzheimer's disease (AD) since it was put forward. Numerous researchers attempted to …